Smith & Nephew Plc

-10.50 (-0.86%)
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Shares Traded Last Trade
  -10.50 -0.86% 1,215.00 3,785,952 16:35:18
Bid Price Offer Price High Price Low Price Open Price
1,211.00 1,211.50 1,227.00 1,209.00 1,224.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Ortho,prosth,surg Appl,suply 5,215.00 223.00 25.40 46.92 10,611.46
Last Trade Time Trade Type Trade Size Trade Price Currency
17:59:39 O 238 1,219.176 GBX

Smith & Nephew (SN.) Latest News

Smart Money!
SN. is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 

Smith & Nephew (SN.) Discussions and Chat

Smith & Nephew Forums and Chat

Date Time Title Posts
21/4/202310:09*** Smith and Nephew ***614
10/1/201113:03Smith and Nephew 200867
09/1/201117:12Smiths: Charts and News etc.296
25/9/200615:09Smith&Nep. Why the rise?75

Add a New Thread

Smith & Nephew (SN.) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Smith & Nephew (SN.) Top Chat Posts

Top Posts
Posted at 21/2/2023 08:42 by adamb1978
Nothing exciting no, but equally still nothing to suggest that they're ever going to deliver decent ROE, ROCE etc

Always felt to me that SN achieves a fraction of its potential. Why...I'm not sure

Posted at 07/12/2022 15:38 by suetballs
Glad this wasn't sn.

Posted at 04/11/2022 17:32 by cerrito
As a SN. holder I listened to most of the recording of yesterday's webcast.
Alot of good stuff especially in logistics and optimization of inventory and US improvement but what stopped me pushing the buy button was not so much the supply shortages(especially semi conductors and resins) but rather that in the Q&A the difficulty they were having on passing on cost increases came up 2/3 times.

Posted at 03/11/2022 10:19 by disc0dave45
Seem to be following the same stocks!From the healthcare sector I've got SN on my watchlist and good to see they are in line. Some of the constraining factors (materials and staff shortages, FX headwinds) could develop into major issues but who knows.
Posted at 06/9/2022 08:48 by roguetraderuk
unless share price were to move up 10% or more then v v unlikely any rns. in any case i think its a passive stake build. any offer is likely going to have to be over 15/16 quid here and its not a level the board will accept at this point. next year i think that that price will be more acceptable. not necessarily because the share price will be much lower at that time (i dont think they go much below 10 maybe to 950 but if they do then 8 is quite prob in that case) but the longer the share price is lower than the more pressure the board will be under to accept a price around 15/16. personally think its still a lot of money to pay inc of all debt so its only the americans that could be interested.
Posted at 25/8/2022 11:56 by 1bearbull
It cannot help in terms of investor confidence when in his first major public appearance he announces a profits warning and if I remember correctly the share fell by 10%.
Posted at 25/8/2022 11:51 by 1bearbull
It is difficult to get excited when a Company has a CEO without any shareholding. Moreover, he can take up to 5 years or so to buy some. What is his incentive to get the share price up?
Posted at 30/7/2022 18:24 by berny3
in light of the price drop after earnings. The transcript of the earnings call is in the below link and also a recording of the call. personally I think the price drop is over done. In particular it is worth listening to the questions at the end. focus was made on this and i think good answers were given.
Posted at 28/7/2022 13:44 by essentialinvestor
£13/4 bn to take this out - plus their £2 bn approx in net debt.

Is SN. worth £15 bn...looks a stretch to me but never say never.

Stryker already carry a lump of debt, realistically only leaves JnJ imv.

Posted at 17/12/2021 14:13 by roguetraderuk
some advice re sn. the share price will begin to outperform when the mkt believes elected surgery for sn. has turned the corner. it will likely go mkt perform as others start giving signals (stryker, medtronic, intuitive etc) but as i say the big outperformance will come when the company points to a return to trend growth. demand issue and supply chains issues all due to covid and the variants are extending the point of turn in trend. i think it should reach equilibrium by q2 2022, i suspect the shares will bottom by then if not sooner. it all depends on the news and if its leaked and other news from others in the area. i dont think they will get too much cheaper as i would expect the americans to start sniffing. there is plenty to put right at sn. but that means a large upside for any buyer. personally i think they will stay independant until jnj do their split and the jnj arm likely picks up sn. but we will see. if they get cheap enough (10 quid or lower) someone may step up earlier. given that they are likely to underperfrom their peers next year, i wouldnt expect outperformance from here now, but of course i cant see the future and a bid would change all that.
Smith & Nephew share price data is direct from the London Stock Exchange
Your Recent History
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230530 18:35:33